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a b s t r a c t
Ethnopharmacological relevance: Dilodendron bipinnatum Radlk. (Sapindaceae), popularly known as
“mulher-pobre”, is a native tree of the Pantanal of Mato Grosso, Brazil. The stem bark of Dilodendron
bipinnatum is used by the population, in the forms of decoction and maceration in the treatment of
inﬂammatory conditions. There is no information in the literature demonstrating the anti-inﬂammatory
activity of Dilodendron bipinnatum and its respective mechanism of action. This study aimed to evaluate
the anti-inﬂammatory activity and mechanism of action of the hydroethanolic extract of the stem bark of
Dilodendron bipinnatum (HEDb) using in vivo and in vitro experimental models.
Materials and methods: The stem bark of Dilodendron bipinnatum was macerated in 70% hydroethanolic
solution (1:3, w/v) for 7 days, ﬁltered, concentrated on a rotary evaporator and the residual solvent
removed in oven at 40 1C, thus obtaining HEDb. Cytotoxicity of HEDb in RAW 264.7 was assessed by the
Alamar blue assay. in vivo anti-inﬂammatory activity of HEDb was evaluated with carrageenan and
dextran-induced paw edemas and lipopolysaccharide (LPS)-induced peritonitis in mice. Effects of HEDb
on the inﬂammatory cytokines (TNF-α, IL-1β and IL-10) concentrations in the peritoneal ﬂuid were
evaluated using commercial ELISA kits. The in vitro anti-inﬂammatory activity was evaluated using RAW
264.7 cells stimulated with LPS and/or INF-γ, while a Griess method was employed to determine nitric
oxide (NO) concentrations in the peritoneal lavage and in the supernatants of RAW 264.7 cells.
Preliminary phytochemical analysis was carried out using classical methods and secondary metabolites
detected on HEDb were analyzed and conﬁrmed by high performance liquid chromatography (HPLC).
Results: HEDb showed very low cytotoxicity with IC50420070.38 μg/mL. HEDb effectively inhibited
paw edema by carrageenan in the 2nd hour at 20 mg/kg (36%, po0.001), and by dextran in the 1st hour
at 100 mg/kg (46%, po0.01), after induction with the phlogistic agents. Furthermore, HEDb reduced total
leukocytes and neutrophils migration at all doses tested producing maximum effect at 20 mg/kg (45%
and 64%, po0.001 respectively). HEDb also attenuated increases in the concentrations of the pro-
inﬂammatory cytokines (IL-1β and TNF-α) and increased the level of the anti-inﬂammatory cytokine
IL-10 in the peritonitis model. However, it had no effect on NO production in activated RAW 264.7 cells.
Preliminary phytochemical analysis revealed the presence of phenolic compounds, chalcones, ﬂavones,
ﬂavonones, ﬂavonoids, saponins and coumarins. HPLC analyses identiﬁed some tannins, with epigallo-
catechin gallate being the major compound.
Conclusions: Our ﬁndings provide evidence for the popular use of the stem bark of Dilodendrum
bipinnatum in inﬂammation. Its anti-inﬂammatory action was due, at least in part, to the inhibition of
cell migration, of the inﬂammatory mediators and Th1 cytokines and an increase in Th2 cytokines,
without affecting NO pathway. It can be suggested that tannins account at least in part for the anti-
inﬂammatory activity of HEDb.
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1. Introduction
Inﬂammation is a response to tissue injury or infection, and it is
characterized in its acute phase by an increase in vascular perme-
ability and plasma extravasation, resulting in accumulation of ﬂuid,
leukocytes and mediators to the inﬂamed site (Guo et al., 2012).
A variety of soluble mediators is involved in the recruitment of
circulating leukocytes and in the regulation of the activation
process of resident cells in the early stages of inﬂammation
(Morais-Lima et al., 2011). These soluble mediators involve lipid
metabolites such as: platelet-activating factor (PAF) and arachido-
nic acid derivatives (eicosanoids), proteases/substrates related to
coagulation and complement system cascade, kinins, nitric oxide
and a group of polypeptide derived cells called cytokines (Kim
et al., 2010).
In addition, an inﬂammatory response is related, in part, to
reactive oxygen species (ROS) released by neutrophils and acti-
vated macrophages (Conforti et al., 2008).
In order to aleviate this situation, anti-inﬂammatory drugs are
used, represented by steroidal agent (SAs) and non-steroidal drugs
(NSAIDs), on symptomatic effects (Gautam and Jachak, 2009). How-
ever, a prolonged use of these agents is followed by severe side
effects such as gastro-duodenal and kidney damage, bone marrow
depression, retention of salts and water, among others (Qandil, 2012).
There is a clinical need to identify new compounds that are safe,
for the prevention and treatment of inﬂammatory diseases (Hur
et al., 2012). Medicinal plants are viable alternative to the discovery
of new safer bioactive compounds (Gautam and Jachak, 2009).
In fact, there are evidences that drugs derived from natural
products modulate various inﬂammatory mediators, including their
effects on the expression of pro-inﬂammatory molecules that are key
to inﬂammation, such as inducible nitric oxide synthase (iNOS),
cyclooxygenase (COX-2), IL-1β, TNF-α and IL-10 cytokines (Bellik
et al., 2013).
Dilodendron bipinnatum (Sapindaceae), commonly known as
“mulher pobre” is a native tree from Pantanal in Mato Grosso,
Brazil, where the habitat is generally semi-deciduous forest.
It occurs in savannah, ﬂooded gallery forests, and develops in
sandy or clay fertile soils (Lorenzi, 2000).
The inner stem bark of Dilodendron bipinnatum is used by the
population, in the form of decoction and macerate, for the
treatments of uterine inﬂammation, bone fractures, general pain
and dermatitis because of its diuretic, stimulant, expectorant,
sedative and anthelmintic properties (Bieski et al., 2012).
In a study involving the pharmacological evaluation of Diloden-
dron bipinnatum, Santos et al. (2010) reported that the ethanolic
extract of the leaves, branches and stem bark were inactive against
Gram-positive and Gram-negative bacteria and to Candida albi-
cans. The same authors described that the leaf and stem bark
extracts present in their composition a mixture of steroids such
as β-sitosterol, stigmasterol, campesterol, 3-O-β-D-sitostenone; as
well as triterpenos: cicloeucalenol and 24-methylene cicloartanol.
As a result of the widespread use of Dilodendron bipinnatum
inner stem bark in popular medicine for inﬂammatory processes
combined with a lack of studies proving the popular beliefs, this
study was carried out aiming to evaluate the anti-inﬂammatory
activity of hydroethanolic extract of Dilodendron bipinnatum, using
in vivo and in vitro experimental models.
2. Material and methods
2.1. Botanic material
Inner stem bark of Dilodendron bipinnatum Radlk. [Family:
Sapindaceae]– Sitzungsber. Math.-Phys. Cl. Königl. Bayer. Akad.
Wiss. München viii. (1878) 357. (IK) (www.ipni.org) used in this
study was harvested from Poconé, Mato Grosso, Brazil, coordinates
S 151560528 and W 051700567. The plant collection was authorized
by the Chico Mendes Institute of Biodiversity Conservation (Insti-
tuto Chico Mendes de Conservação da Biodiversidade - ICMbio),
registry number 14360, while access to the associated traditional
knowledge and to genetic patrimony for the purpose of research
was authorized by the Council on Genetic Patrimony of the
Ministry of Environment (CGEN/MMA) under registry number
045/2009. Botanical identiﬁcation was done at the Herbarium
of Federal University of Mato Grosso and voucher specimen
(No. 20,529) was deposited at the same Herbarium. Since Diloden-
dron bipinnatum is not included in the list of endangered Brazilian
plants, as such, its collection for the purpose of scientiﬁc studies
does not require prior authorization by the Brazilian Institute of
Environment and Renewable Natural Resources (IBAMA/MMA).
2.2. Animals
Male albino Wistar rats (180–200 g) and male Swiss mice
(25–30 g) were used for the studies. Animals were maintained in
propylene cages at 2671 oC in a 12 h dark/12 h light cycle, with
free access to standard laboratory chow and water. Groups of six to
eight animals were used for each experiment. The experimental
protocol followed the International Principles for the Biomedical
Research Involving Animal (CIOMS/OMS, 1985) and was approved
by the Committee on the Use of Animal for experimentation
(CEUA/UFMT) with Protocol no. 23108.015729/13-0.
2.3. Cell culture
Murine macrophage-like RAW 264.7 cell lines were obtained
from the Cell Bank of Rio de Janeiro. The cells were maintained in
DMEM (Dulbecco's modiﬁed Eagle's Medium plus 10% fetal bovine
serum), supplemented by penicillin (100 U/mL) and streptomycin
(100 μg/mL), under a temperature of 37 1C, and atmosphere of 5%
of CO2 and 90% humidity.
2.4. Drugs and reagents
Carrageenan, dextran, Escherichia coli lipopolysaccharide (sero-
types 055:B5 and 055:B8), dexamethasone acetate, indomethacin,
ethylenediaminetetraacetic acid (sodium-EDTA), N-ω-Nitro-L-argi-
nine methyl ester hydrochloride (L-NAME), cyproheptadine, Griess
reagent and sodium nitrite were obtained from Sigma (USA).
Doxorubicin was acquired from Fluka (USA), Alamar Blue from
Invitrogen and interferon-γ from Preprotec (Brazil). HPLC standards
used were gallic acid (Vetecs 444), ()-gallocatechin (Sigmas
G6657), (þ)catechin (Sigmas C1251) and ()-epigallocatechin-
gallate. All reagents and drugs used were of analytical grade.
2.5. Extract preparation
The inner stem bark of Dilodendron bipinnatum was cleaned,
dried at room temperature, and milled in an electric mill (model
TE-625 TECNAL, São Paulo, Brazil) coupled with mesh sieve
size 40. The dried powder (200 g) obtained was macerated in
70% hydroethanolic solution (1:3, w/v) for 7 days, ﬁltered and
concentrated in a rotary evaporator (Marconi MA 120, São Paulo,
Brazil) under reduced pressure of 600 mm Hg at 40 1C. The
residual solvent was eliminated in an oven at 45 1C, for 24 h,
obtaining hydroethanolic extract of Dilodendron bipinnatum
(HEDb) (with a yield of 16.02% w/w), which was stored in amber
bottle and kept at 4 1C. At the time of use, HEDb was dissolved in
distilled water to obtain the desired concentration.
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2.6. Phytochemical analysis
2.6.1. Preliminary phytochemical screening
Preliminary phytochemical tests for secondary metabolites
present in HEDb was performed according to the methods
described by Matos (2009), which rely on chemical reactions of
coloration, precipitation and foam formation.
2.6.2. Fingerprint HPLC analysis
The experiment was performed using a high performance
liquid chromatography (HPLC-Shimadzuschromatograph - LC-10
Avp series, Japan) equipped with a pump (LC-10AD), degasser
(DGU-14A), UV–vis detector (SPD-10A), oven column (CTO-10A),
rheodyne manual injector (loop 20 μL) and integrating CLASS (LC-
10A). The extract was dissolved in the eluting solvent and the
standard in methanol. All solutions were ﬁltered with Millipore
membrane (0.45 mM pore diameter). The samples were eluted
using a Phenomenex Luna reverse phase column C18 5 mm (2)
(2504.6 mm) and Phenomenex C18 pre-column (43.0 mm)
ﬁlled with similar material to the main column. The chromato-
graphic separation of the compounds was carried out in isocratic
elution using methanol/water Milli-Q/methanol (1:18:1), at 40 1C
and ﬂow of 1 mL min1. The quantiﬁcation was performed and
expressed in micrograms per milligram of extract (μg/ mg),
correlating the area of the analyte with the calibration curve of
standards built in concentrations of 125–1000 μg/mL. The extract
solutions and standards were prepared with methanol and ﬁltered
through a Millipores (0.45 mM pore size) membrane as previously
described by Tamashiro-Filho et al. (2012).
2.7. Cell viability assay
RAW 264.7 cells, of density 2104 cells per dish were plated
on a 96-well microplate containing medium (growth control)
with/without HEDb with concentration range from 3.125 to
200 mg/mL. Doxorubicin (0.0058–58 mg/mL) was used as a positive
control. After incubation for 24 h at 37 1C and 5% CO2, the
treatments were removed and 200 mL of 10% Alamar Blue solution
was added (Nakayama et al., 1997). After 5 h, absorbance plate at
540 nm for oxidized state and 620 nm for reduced state, through
ELISA reader (Bio-Tek, Elx800), and then cell viability was calcu-
lated. Drugs that presented IC50 o50 mg/mL were considered
cytotoxic (Fröelich et al., 2007).
2.8. in vivo anti-inﬂammatory assay
2.8.1. Paw edema induced by carrageenan and dextran
The animals were orally treated with vehicle (distilled water),
HEDb (20, 100 and 500 mg/kg) and indomethacin (5 mg/kg)
dissolved in 2% (w/v) sodium bicarbonate. After 1 h, 0.1 mL of 1%
carrageenan was injected in posterior left paw of each animal and
the same amount of 0.9% sterile sodium chloride solution was
injected in the contralateral paw. The volume of each paw was
measured using digital plethysmometer (Model 7140, Ugo Basile,
Italy) 0, 1, 2, 3 and 4 h after the phlogistic stimulus injection.
The measurement variation (mL) between right and left paws
represented edema volume (Winter et al., 1962).
In the case of dextran-induced paw edema, the procedure was
the same as used for carrageenan, except that cyproheptadine
(5 mg/kg) was used as positive control and the edema measure-
ments were carried out at 0, 15, 30, 60 and 120 min after the
injection.
2.8.2. Peritonitis induced by lipopolysaccharide
In order to evaluate the effect of HEDb on leukocyte recruit-
ment into the peritoneal cavity, the mice were orally pre-treated,
with vehicle (0.9% saline solution), HEDb (20, 100 and 500 mg/kg)
or dexamethasone (0.5 mg/kg). After 1 h, LPS (250 ng/cavity/
0.2 mL), of Escherichia coli dissolved in sterile saline solution was
administered intraperitoneally. Six hours after the intraperitoneal
injection of LPS, mice were anesthetized with 180 mg/kg ketamine
and 30 mg/kg xylazin by intraperitoneal (ip.) and the cells in
the peritoneal cavity were collected through injection of 3 mL
saline solution containing EDTA. The abdomen was slightly
massaged and the cell suspension was aspirated using a syringe.
The peritoneal lavage collected was used for cellular counting
in Neubauer chamber, while an aliquot of the lavage was used
to make smear for differential counting. Aliquots of peritoneal
washing were stored in a freezer at 80 1C for posterior dosage of
cytokines (Cunha et al., 1989; Orlandi et al., 2011).
2.8.3. Cytokine quantiﬁcation in the peritoneal lavage
The levels of cytokines (pg/mL) TNF-α, IL-1β and IL-10 were
determined using ELISA kit (eBioscience, USA), in accordance
with manufacturer's instructions. Microplate reader Multiskans
(Thermo Scientiﬁc, EUA) was used for reading the absorbance.
2.9. in vitro anti-inﬂammatory assay
2.9.1. Nitrite dosage
Nitrite (NO2), a stable product from nitric oxide (NO), was used as
an indicator of NO production in the culture medium. Nitrite released
in the culture medium was measured according to the Griess
reaction (Minghetti et al., 1997). In summary, RAW cells 264.7
(1.0106 cells/dish) were plated in a 24-well plate overnight. Cells
were pre-treated with HEDb at concentrations of 1, 5 and 20 mg/mL
for 1 h, and incubated at 37 1C and 5% CO2. Next, the cells were
stimulated with LPS (0.5 mg/mL) and/or IFN-γ (0.5 ng/mL) for 24 h, in
the presence or absence of HEDb (1, 5 and 20 mg/mL) under the same
condition. L-NAME (2.69 mg/mL), a speciﬁc inhibitor of iNOS, was
used as a positive control. For negative control, the same amount of
medium was used in the microplate well. Supernatant from cell
culture was measured for nitrite concentration and 100 mL of it was
mixed with the same volume of Griess reagent for 10 min at room
temperature. Absorbance (540 nm) was measured using a microplate
reader and nitrite concentration was determined using a standard
curve of sodium nitrite prepared in RPMI-1640 exempt of phenol red.
2.10. Data analysis
The results were expressed as mean7standard error of mean
(x̄7SEM). Comparisons between means were analyzed by one-way
analysis of variance (Anova). When signiﬁcant, it was followed by
Student-Newman–Keuls test for multiple comparisons. P values
o0.05 were considered signiﬁcant. In vitro assays were performed
in triplicate. All values were analyzed with GraphPad Prisms soft-
ware version 5.01 GraphPad Software, Inc. La Jolla, CA 92037 USA
www.graphpad.com.
The IC50 was determination from a linear regression relating
the percentage of inhibition versus the logarithm of the concen-
trations tested and assuming a conﬁdence level of 99% (po0.01)
for the straight obtained. For in vitro assays that do not involve
statistical analysis, we used the mean 7SEM three independent
experiments performed in duplicate.
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3. Results
3.1. Preliminary phytochemical screening
Preliminary phytochemical screening of HEDb revealed the
presence of phenols, chalcones, ﬂavonoids, saponins and coumar-
ins. The phenols identiﬁed were conﬁrmed qualitatively and
quantitatively by HPLC.
3.2. Fingerprint HPLC analysis
Analysis by HPLC conﬁrmed the presence of phenolic com-
pounds detected in the preliminary analysis (Fig. 1). These com-
pounds in HEDb were analyzed and revealed the presence of gallic
acid (GA, retention time 4.87 min at a concentration of 0.30 mg of
GA/g of HEDb, representing 0.03% of the extract), ()-gallocate-
chin (retention time 5.99 min, qualitatively analyzed), (þ)cate-
chin (CAT, retention time 13.97 min) at concentration of 7.74 mg of
CAT/g of HEDb (0.77% of extract) and gallate of ()-epigallocate-
chin (EGTC) (retention time 27.62 min) at concentration of
10.98 mg of EGTC/g of HEDb (1.10% of extract).
3.3. Cell viability assay
Fig. 2 shows the cell viability curve of RAW cells 264.7 treated
with decreasing concentrations of HEDb and doxorubicin. The
extract demonstrated to be non-cytotoxic with IC5042007
0.38 mg/mL, while doxorubicin, the positive control in this assay,
was highly cytotoxic with IC50 of 4.872.56 mg/mL.
3.4. in vivo anti-inﬂammatory assay
3.4.1. Paw edema induced by carrageenan and dextran
For the group treated with vehicle, a slow and progressive
volume increase of the posterior intraplantar left paw injected
with 0.1 mL of 1.0% carrageenan was observed, reaching the peak
of edema at the 3rd hour (0.6170.05 mL). The effect of HEDb
at 20, 100 and 500 mg/kg caused a non-dose-dependent reduction
of the edema until the 3rd hour, in all doses, reaching a maximum
effect (36%, po0.01) at the dose of 20 mg/kg. Indomethacin
(5 mg/kg) also reduced signiﬁcant edema until the 3rd hour,
producing the greatest effect at the second hour (32%, po0.01),
as shown in Fig. 3.
In the group of rats orally treated with the vehicle, the
intraplantar injection of 0.1 mL of 1.5% dextran promoted an
edema characterized by sudden onset and reaching the peak at
30 min (0.7270.05 mL), as shown in Fig. 4. HEDb was active only
in the ﬁrst hour after induction at the dose of 100 mg/kg, reducing
the paw edema by 46% (po0.01). Cyproheptadine (5 mg/kg)
caused an intense inhibition of paw edema at all times, with the
effect starting from 15 min (42.8%, po0.01) after induction and
reaching the peak (91.5%, po0.001) at 30 min.
3.4.2. Peritonitis induced by lipopolysaccharide
3.4.2.1. Total leukocytes. In LPS-induced peritonitis, the sham
group (distilled water p.o. and 0.9% sterile saline solution, ip.)
Fig. 1. HPLC chromatogram of authentic standards tested (A) and HPLC ﬁngerprint of hydroethanolic extract of Dilodendron bipinnatum (B), detected at 280 nm. Peak 1:
gallic acid (time 4.87 min.) 2: () gallocatechin (time 5.99 min.); 3: (þ)-catechin (time 13.97 min.); 4: gallate of ()-epigallocatechin (time 27.62 min).
Fig. 2. Cell viability curve of RAW 264.7 cells exposed to varying concentrations of
hydroethanolic extract of Dilodendron bipinnatum inner stem bark (HEDb) and
doxorubicin for 24 h. Expressed as minimum inhibitory concentration 50% (IC50).
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presented 7.970.47106 total leukocytes in the peritoneal cavity.
The intraperitoneal injection of 250 ng of LPS (0.2 mL/cavity)
in mice of the vehicle group caused a signiﬁcant increase
(77.0%; po0.001) in leukocyte migration to the peritoneal
cavity compared to the sham group. Pre-treatment with HEDb
(20, 100 and 500 mg/kg p.o.) caused reduction in leukocyte
migration and attaining maximum effect at the dose of 20 mg/kg
(45.4%, po0.001) compared to vehicle group. Pre-treatment
with dexamethasone at 0.5 mg/kg, inhibited leukocytes inﬂuxes
by 50.8% (po0.001) when compared to the vehicle group
(Fig. 5).
3.4.2.2. Differential cell counting. In the sham group, the number of
neutrophils present in the peritoneal cavity was 4.770.48106.
In the vehicle group, LPS injection caused an increase of 79.1%
(po0.001) in the number of neutrophils that migrated to the
peritoneal cavity, compared to the sham group.
HEDb reduced neutrophil migration at all doses tested, in a non
dose-dependent manner and producing greater effect at the dose
of 20 mg/kg (64.0%, po0.001), in comparison to the vehicle group,
while in dexamethasone treated group, the reduction was 69.8%
(po0.001) as shown in Fig. 6.
3.4.2.3. Cytokines quantiﬁcation in the peritoneal lavage. As shown
in Fig. 7, the concentration of TNF-α in peritoneal lavage of
animals from sham group was 8.671.95 pg/mL. In the vehicle
group, which received an intraperitoneal injection of LPS, pre-
sented a signiﬁcant increase of 94.8% (po0.001) of this cytokine,
compared to sham group.
HEDb reduced TNF-α concentration in the peritoneal lavage, at
all doses tested (in non dose-dependent manner), with 100 mg/kg
having the maximum effect (65.8%, po0.001), while with dex-
amethasone, the reduction was 78.6% (po0.001), in comparison to
vehicle group.
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Fig. 3. Effect of oral administration of vehicle (1 mL of distilled water/100 g), 70%
hydroethanolic extract of Dilodendron bipinnatum inner stem bark (HEDb 20, 100,
and 500 mg/kg), and 5 mg/kg indomethacin on paw edema induced by 1%
carrageenan in rats. Each point represents a mean of 6 animals. The vertical lines
represent S.E.M. One-way analysis of variance, followed by Student-Newman–Keuls
test. nn po0.01 and nnn po0.001 vs. vehicle.
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Fig. 4. Effect of oral administration of vehicle (1 mL of distilled water/100 g), 70%
hydroethanolic extract of Dilodendron bipinnatum inner stem bark (HEDb 20, 100,
and 500 mg/kg), and cyproheptadin (Cyp – 5 mg/kg) on paw edema induced by
1.5% dextran in rats. Each point represents a mean of 6 animals. The vertical lines
represent S.E.M. One-way analysis of variance, followed by Student-Newman–Keuls
test. nn po0.01 and nnn po0.001 vs. vehicle.
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Fig. 5. Effect of oral administration of vehicle (0.1 mL/10 g), 70% hydroethanolic
extract of Dilodendron bipinnatum inner stem bark (HEDb-20, 100, and 500 mg/kg),
and dexamethasone (Dexa-0.5 mg/kg) on total number of leukocytes present in the
peritoneal lavage of male mice with LPS-induced peritonitis (250 ng LPS/0.2 mL/
cavity). The sham group received vehicle (1 mL water/10 g, p.o) and intraperitoneal
injection of 0.9% sterile saline solution (0.1 mL/10 g). Each point represents a mean
of 8 animals. The vertical lines represent S.E.M. One-way analysis of variance,
followed by Student-Newman–Keuls test. ††† po0.001 vs. sham; nn po0.01 and nnn
po0.001 vs. vehicle.
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Fig. 6. Effect of oral administration of vehicle (0.1 mL/10 g), hydroethanolic extract
70% of Dilodendron bipinnatum inner stem bark (HEDb-20, 100, and 500 mg/kg),
and dexamethasone (Dexa-0.5 mg/kg) on number of neutrophils present during
peritoneal lavage of male mice with peritonitis LPS-induced (250 ng LPS/0.2 mL/
cavity). The sham group received vehicle (water, 1 mL/10 g, v.o) and an intraper-
itoneal injection of 0.9% saline solution sterile (0.1 mL/10 g). Each point represents a
mean of 8 animals. The vertical lines represent S.E.M. One-way analysis of variance,
followed by Student-Newman–Keuls test. ††† po0.001 vs. sham; nn po0.01 and nnn
po0.001 vs. vehicle.
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As shown in Fig. 8, the concentration of IL-1β determined in the
peritoneal lavage of animals from the sham group was
5.970.84 pg/mL. Vehicle group presented an increase of 94.4%
(po0.001), of the concentration of this cytokine, in comparison to
sham group.
HEDb treatment attenuated the increase in the concentration
of IL-1β at all dose tested, in a non-dose-dependent manner,
with maximum effect being at the dose of 500 mg/kg (91.7%,
po0.001), whereas with dexamethasone, the inhibition was 89.4%
(po0.001) when compared to the vehicle group.
As shown in Fig. 9, the concentration of IL-10 determined
in the peritoneal lavage of animals from the sham group was
279.5719 pg/mL. The intraperitoneal injection of LPS in the
vehicle group did not signiﬁcantly alter the concentration of
IL-10 (188.2710.9 pg/mL) in comparison to the sham group
(p40.05).
HEDb increased the concentration of IL-10 in the peritoneal
lavage at all doses tested, in a non-dose-dependent manner, with
the peak effect at the dose of 100 mg/kg (53.6%, po0.001), while
dexamethasone did not alter at the concentration of this cytokine
(271.8728.4 pg/mL, p40.05) in comparison to the vehicle group.
3.5. Evaluation of in vitro anti-inﬂammatory activity
3.5.1. Nitrite dosage
The basal nitrite concentration in non-stimulated RAW cells
264.7 was 0.170.23 mM. The vehicle group, which was stimulated
with LPS 0.5 mg/mL or co-stimulated with LPS 0.5 mg/mL and IFN-γ
0.5 ng/mL presented, increases of 95.7% and 94.9% (po0.001)
respectively, in the nitrite concentration, compared to the
sham group.
Pre-treatment with HEDb (1, 5 and 20 mg/mL) did not alter
(p40.05) nitrite levels in the cellular supernatant stimulated by
LPS or LPS with IFN-γ, in comparison to vehicle group. L-NAME
(2.69 mg/mL), the standard used in the assay, inhibited nitrite
production by 79.4% and 57.9% in the LPS and LPS with IFN-γ
respectively, compared to the vehicle group (po0.001).
4. Discussion
The scientiﬁc evidence of the popular use of HEDb in inﬂam-
matory processes has been demonstrated by Mahon (2012).
In order to evaluate possible mechanisms of action involved in
the anti-inﬂammatory action of HEDb, in vivo and in vitro inﬂam-
mation models were employed in this present study.
Towards this end, carrageenan induced paw edema was used.
In this inﬂammatory model, oral treatment of HEDb present
antiedemal activity at all the three doses tested, which suggests
that the extract acts by the inhibition of mediators related to
arachidonic acid, prostaglandin and cyclooxygenase pathways
(Silva et al., 2005). However, further studies are needed to
elucidate this mechanism of action.
Due to the promising result obtained in the preliminary
screening with carrageenan-induced paw edema, we sought to
investigate the effects of HEDb in other animal models of acute
inﬂammation.
Edema produced by subplantar injection of dextran in animals
is characterized by a rapid increase in the paw edema and
spontaneous decrease after 30 min, with histamine and serotonin
being the main mediators (Lo et al., 1982; Calixto, 2005).
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Fig. 7. Effect of oral administration of vehicle (0.1 mL/10 g), 70% hydroethanolic
extract of Dilodendron bipinnatum inner stem bark (HEDb-20, 100, and 500 mg/kg),
and dexamethasone (Dexa-0.5 mg/kg) on the concentration of TNF-α, on peritoneal
lavage of male mice with peritonitis LPS-induced (250 ng LPS/0.2 mL/cavity). The
sham group received vehicle (water, 1 mL/10 g, v.o) and intraperitoneal injection of
0.9% sterile saline solution (0.1 mL/10 g). Each point represents a mean of 8 animals.
The vertical lines represent S.E.M. One-way analysis of variance, followed by
Student-Newman–Keuls test. ††† po0.001 vs. sham; nn po0.01 and nnn po0.001
vs. vehicle.
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Fig. 8. Effect of oral administration of vehicle (0.1 mL/10 g), 70% hydroethanolic
extract of Dilodendron bipinnatum inner stem bark (HEDb-20, 100, and 500 mg/kg),
and dexamethasone (Dexa-0.5 mg/kg) on the concentration of Interleukin-1β (IL-
1β), on peritoneal lavage of male mice with peritonitis LPS-induced (250 ng LPS
/0.2 mL/cavity). The sham group received vehicle (water, 1 mL/10 g, v.o) and
intraperitoneal injection of 0.9% sterile saline solution (0.1 mL/10 g). Each point
represents a mean of 8 animals. The vertical lines represent S.E.M. One-way
analysis of variance, followed by Student-Newman–Keuls test. ††† po0.001 vs.
sham; nnn po0.001 vs vehicle.
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Fig. 9. Effect of oral administration of the vehicle (0.1 mL/10 g), 70% hydroethanolic
extract of Dilodendron bipinnatum inner stem bark (HEDb-20, 100, and 500 mg/kg), and
dexamethasone (Dexa-0.5 mg/kg) on the concentration of Interleukin 10 (IL-10), on
peritoneal lavage of male mice with peritonitis LPS-induced (250 ng LPS/0.2 mL/cavity).
The sham group received vehicle (water, 1 mL/10 g, v.o) and intraperitoneal injection of
(0.1 mL/10 g). Each point represents a mean of 8 animals. The vertical lines represent S.
E.M. One-way analysis of variance, followed by Student-Newman–Keuls test. n po0.05,
nn po0.01, nnn po0.001 vs. vehicle.
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HEDb at the dose of 100 mg/kg presented a reduction in
dextran-induced paw edema in the ﬁrst hour only, indicating
that the anti-edematogenic activity observed in this model could
be related to the inhibition of histamine and serotonin releases
(Stucki and Thompson, 1958). It is interesting to note that only the
intermediate dose was effective, the exact mechanism responsible
for this kind of effect is not known.
Although experimental models of carrageenan-induced and
dextran-induced paw edema are important to evaluate the poten-
tial of anti-inﬂammatory drugs, they are not suitable for quantify-
ing the cellular component of an acute inﬂammatory response,
where neutrophils are particularly relevant (Vinegar et al., 1987).
In this way, HEDb was evaluated in an LPS-induced leukocyte
migration model (Orlandi et al., 2011).
During the course of inﬂammation induced by LPS, the neu-
trophils and the macrophages are the principal cells involved
(Pinho et al., 2011). A reduction in the leukocyte migration by
HEDb was accompanied by inhibition in the accumulation of
the neutrophils to the site of inﬂammation, indicating that
inhibition of this polymorphonuclear cell is involved in the anti-
inﬂammatory action of the extract.
In peritonitis caused by LPS, phagocytes synthesize and release
several mediators, including pro-inﬂammatory cytokines such as
TNF-α and IL-1β and anti-inﬂammatory IL-10. Pre-treatment of
animals with HEDb resulted in reductions of TNF-α and IL-1β
comparable to dexamethasone and, surprisingly, increased the
levels of IL-10, unlike the standard drug which, in this model did
not cause increase in the production of this cytokine.
IL-1β exerts a strong pro-inﬂammatory activity and it is
produced mainly by macrophages and to a lesser extent by
neutrophils, lymphocytes, endothelial cells and other cell types
(Gabay et al., 2010). IL-1β is important for initiation and increased
inﬂammatory response to the proliferation of certain microorgan-
isms (Pinho et al., 2011). It plays a key role in acute and chronic
inﬂammatory and autoimmune diseases (Dinarello, 2010). IL-1β
promotes the recruitment of inﬂammatory cells to the site of
inﬂammation by inducing the expression of adhesion molecules
on endothelial cells and release of chemokines by stromal cells
(Gabay et al., 2010).
TNF-α, primarily produced by macrophages and to a lesser
extent by other cell types (Chu, 2013) is the prototype of pro-
inﬂammatory cytokines, because it not only induces its own
secretion, but also stimulates the production of other inﬂamma-
tory cytokines and chemokines (McDermott, 2001). This cytokine
has been directly implicated as a mediator of septic shock,
inﬂammation and cytotoxicity (Aggarwal and Natarajan, 1996).
Like IL-1β, TNF-α plays an important role in the control of
leukocyte migration, especially of neutrophils, by increasing the
expression of adhesion molecules on the surface of endothelial
cells and chemokines such as MCP-1 which contribute to the
recruitment of circulating monocytes into the tissues (Cavaillon,
1994).
Studies have shown that IL-10 controls the degree and duration
of the inﬂammatory response, acting as a potent anti-inﬂam-
matory cytokine, affecting both Th1 and Th2 responses. Its main
effect is due to the selective blockade of expression of genes
encoding cytokines (TNF-α, IL-1β and IL-6 mRNA) and
pro-inﬂammatory CXR chemokines (MCP-1, IL-8, IP-10 and MIP
-2) in myeloid cells activated by PRR ligands such as LPS (Moore et
al., 2001). Accordingly, IL-10 causes blockade of cellular migration,
especially the initial inﬂux of neutrophils to the site of the injury
(Bazzoni et al., 2010).
Based on these results, a model for signaling induced by EHDb
in peritonitis induced by LPS is proposed here. First, HEDb may be
acting directly or indirectly, by inhibiting the activation of TLRs by
LPS and thereby leading to reduced cell migration, and in turn,
reducing the release of pro-inﬂammatory cytokines in the perito-
neal cavity. Second, HEDb may be acting directly through the
inhibition of the production or release of pro-inﬂammatory
cytokines such as TNF-α and IL-1β, and by reducing the release
of other inﬂammatory mediators which are important in the
induction and maintenance of inﬂammatory response caused by
LPS. Third, HEDb may be acting directly or indirectly (via IL-10) by
increasing the expression of anti-inﬂammatory molecules. Fourth,
HEDb may be acting directly or indirectly by the activation of
IL-10R receptor, and ultimately inducing expression of genes that
inhibit the synthesis of new proteins by neutrophils and macro-
phages, including pro-inﬂammatory cytokines (IL-1β, TNF and
IL-8) (Bazzoni et al., 2010).
The increasingly restricted use of tests with laboratory animals
has led to the development of alternative in vitro methods.
Compared to the in vivo methods, in vitro methods offer the
following advantages: limited number of experimental variables;
simpler acquisition of meaningful data, and short test period
(Rogero et al., 2003).
In the present study, we evaluated the viability of RAW
264.7 cells with different concentrations of HEDb cells using the
Alamar Blue method (Nakayama et al., 1997). HEDb presented
IC504200 mg/mL, indicating its very low cell toxicity according to
criteria established by Fröelich et al. (2007).
Analysis of cell viability does not only enable evaluation of
cytotoxicity superﬁcially, but also in the selection of the concen-
trations of HEDb to be used for the in vitro anti-inﬂammatory
assays.
RAW 264.7, a murine macrophage cell line was selected for the
in vitro studies of mechanisms of action, and has been shown to be
an excellent model for screening anti-inﬂammatory drugs and
subsequent evaluation of inhibitors of the pathways that lead to
induction of pro-inﬂammatory enzymes and cytokines (Yang et al.,
2012).
in vitro studies to elucidate the possible mechanisms involved
in the anti-inﬂammatory action HEDb were performed in RAW
264.7 cells activated by LPS and/or IFN-γ, since among immune
systems that participate in host defense, macrophages are the
main cells targeted by this bacterial endotoxin (Lai et al., 2013).
NO, a reactive nitrogen species is produced from iNOS and has
important biological functions including vasodilation, immunor-
egulation, inﬂammation, and neurotransmitter. This small gas
molecule modulates the synthesis of prostaglandins, thrombox-
anes and other inﬂammatory molecules (Moncada et al., 1991).
The increase of NO in RAW 264.7 activated with LPS and IFN-γ was
not affected by pre-treatment with HEDb, indicating that the anti-
inﬂammatory activity of the extract is independent of the mod-
ulation of the NO.
Chemical analysis revealed the presence of gallic acid, galloca-
techin, catechin and epigallocatechin gallate in HEDb, the latter
being the major compound.
Activities and possible mechanisms of anti-inﬂammatory
action of these four tannins are well documented in the literature
and involve actions on different targets of the inﬂammatory
process (Kroes et al., 1992; Delporte et al., 2003; Geraets et al.,
2009; Singh et al., 2010; Hirao et al., 2010; Muthuraman et al.,
2011).
Based on preliminary phytochemical analysis, it can be stated
that the anti-inﬂammatory action of HEDb, depends at least in
part, on the synergistic interaction of the four tannins identiﬁed by
the HPLC technique. One cannot rule out the possibility of other
compounds belonging to different metabolic classes contributing
to the anti-inﬂammatory action of HEDb, since in the preliminary
phytochemical analysis of the extract chalcones, ﬂavonoids,
saponins and coumarins were found in addition to the phenols.
Santos et al. (2010) showed that the ethanol extract of leaves,
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branches and stem of the Dilodendron bipinnatum present steroids
(β-sitosterol, stigmasterol, campesterol and 3-O-β-D-sitostenone)
and triterpenes (cicloeucalenol and) all of proven anti-
inﬂammatory activities (Safayhi and Sailer 1997; Gabay et al.,
2010; Loizou et al., 2010; Kaur et al., 2011).
As can be seen in most of the experiments, a non-dose
dependent effect of HEDb was observed. The exact mechanism
by which the extract produced a non-dose dependent effect is
unknown. However, there are plausible hypotheses to explain this
phenomenon. The crude extract is composed of complex of
phytochemical compounds whose diverse biological and pharma-
cological effects are well documented. Many of these compounds
are known to be pleiotropic, producing multiple effects by acting
on several cellular and or molecular targets (Vattem and Shetty,
2005). In this manner, it is possible that a single molecular entity
may produce different functional outputs. Likewise, from the
perspective of ligand-receptor interactions, there could be an
agonism, partial agonism or even antagonism effects due to the
combined actions of the various phytoconstituents (Vattem and
Shetty, 2005; Spedding, 2011). In addition, various factors such as
onsets and offsets kinetics, functional selectivity (ligand induced
differential signaling) and a host of others determine the ultimate
effect of even a single compound, and therefore by extension may
be the case with a crude extract. As noted in the review of Vattem
and Shetty (2005), some phytochemicals have been shown to
interact with proteins and to alter their conﬁgurations, and can
directly interact with the cell surface receptors and ion pumps,
thus directly activating signaling cascades. These signaling cas-
cades can result in the changes in many physiological pathways.
The in vivo and in vitro results provided evidence for the popular
use of the stem bark of Dilodendron bipinnatum in inﬂammation.
HEDb presented innovative multitargeted anti-inﬂammatory action
mechanisms and was non-cytotoxic. Its anti-inﬂammatory action
was due, at least in part, to the inhibition of cell migration and
mediators of the inﬂammatory response, by inhibiting Th1
cytokines and stimulating Th2 cytokine without affecting the NO
pathway. It can be suggested that the tannins are responsible, at
least in part for the anti-inﬂammatory activity of HEDb.
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